Novartis
- All
- News
- Videos
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Gujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old Son
A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
-
Just Approved Gene Therapy Drug Is World's Most Expensive At $2.1 Million
The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants.
-
Google Parent Alphabet's Verily Unit Halts Glucose-Detecting Contact Lens Project
Verily, which was previously part of the tech firm's Google X research and development unit, had partnered with Novartis' eye-care division, Alcon, to develop the lens.
-
Swiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For Malaria
Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.
-
Ten Greek Ex-Ministers Allegedly Involved In Novartis Bribery Probe
Two former Greek prime ministers and eight former ministers have been implicated in an alleged corruption scandal involving Swiss pharmaceutical giant Novartis, a judicial source said Monday.
-
India-Origin Vasant Narasimhan Named CEO Of Novartis
Vasant Narasimhan is among a new generation of leaders at Novartis who have sought to improve the process in which drugs move from research to actually becoming a commercial product.
-
ISB 2017 Placements: Average Salary Of Rs 22 Lakh, Over 400 Recruiters
Regular recruiters at ISB placement activities included Microsoft, Citibank, Amazon, Cognizant, and Hindustan Unilever, Novartis, Siemens, McKinsey, BCG, Parthenon and AT Kearney.
-
Compound Found To Treat 3 Parasitic Tropical Diseases
In a study published in the journal Nature, scientists at the Genomics Institute of the Novartis Research Foundation found the compound can cure all three diseases in mice, and does not harm normal human cells in laboratory tests.
-
New Heart Drugs Struggle To Win Sales As Doctors Hold Back
New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine today.
-
Drug Defies A Rare Form Of Cancer - And Market Logic
When the drug company Novartis launched its breakthrough cancer medicine, Gleevec, in 2001, the list price was $26,400 a year. The company's chief executive acknowledged it was expensive, calling it an "uphill battle to win understanding for our decision."
-
Novartis Digs Into Health Tech With Bet on 'Robotic Pill'
The Rani capsule contains tiny needles made of sugar that are pushed into the wall of the intestine to deliver the drug.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Gujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old Son
A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
-
Just Approved Gene Therapy Drug Is World's Most Expensive At $2.1 Million
The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants.
-
Google Parent Alphabet's Verily Unit Halts Glucose-Detecting Contact Lens Project
Verily, which was previously part of the tech firm's Google X research and development unit, had partnered with Novartis' eye-care division, Alcon, to develop the lens.
-
Swiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For Malaria
Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.
-
Ten Greek Ex-Ministers Allegedly Involved In Novartis Bribery Probe
Two former Greek prime ministers and eight former ministers have been implicated in an alleged corruption scandal involving Swiss pharmaceutical giant Novartis, a judicial source said Monday.
-
India-Origin Vasant Narasimhan Named CEO Of Novartis
Vasant Narasimhan is among a new generation of leaders at Novartis who have sought to improve the process in which drugs move from research to actually becoming a commercial product.
-
ISB 2017 Placements: Average Salary Of Rs 22 Lakh, Over 400 Recruiters
Regular recruiters at ISB placement activities included Microsoft, Citibank, Amazon, Cognizant, and Hindustan Unilever, Novartis, Siemens, McKinsey, BCG, Parthenon and AT Kearney.
-
Compound Found To Treat 3 Parasitic Tropical Diseases
In a study published in the journal Nature, scientists at the Genomics Institute of the Novartis Research Foundation found the compound can cure all three diseases in mice, and does not harm normal human cells in laboratory tests.
-
New Heart Drugs Struggle To Win Sales As Doctors Hold Back
New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine today.
-
Drug Defies A Rare Form Of Cancer - And Market Logic
When the drug company Novartis launched its breakthrough cancer medicine, Gleevec, in 2001, the list price was $26,400 a year. The company's chief executive acknowledged it was expensive, calling it an "uphill battle to win understanding for our decision."
-
Novartis Digs Into Health Tech With Bet on 'Robotic Pill'
The Rani capsule contains tiny needles made of sugar that are pushed into the wall of the intestine to deliver the drug.
